AHFS May 2022 Update

This update contains 2 new monographs and 25 revised monographs.

New monographs: Nivolumab and Relatlimab-rmbw; Pacritinib

Revised monographs: Acalabrutinib; Adalimumab; Brigatinib; Brodalumab; Certolizumab; COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Eptinezumab-jjmr; Erenumab-aooe; Fremanezumab-vfrm; Glatiramer; Imatinib; Infigratinib; Lanadelumab; Lurbinectedin; Nilotinib; Nitroglycerin; PAZOPanib; Pramipexole; Rimegepant; Sotrovimab; Teduglutide; Tivozanib; Trihexyphenidyl; Upadacitinib